Interestingly, Wee1-AS infusion led to a slight increase in complex I activity in the LFD-fed group, suggesting that mitochondrial function may be modulated prior to the onset of the MASLD phenotype (Supplementary Fig. 3f). Here, WEE1 is linked to metabolic dysfunction-associated steatotic liver disease.